Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
16 studies found for:    SAILS
Show Display Options
Rank Status Study
1 Recruiting Virtual Sailing Simulator in Individuals With Spinal Cord Injury
Condition: Spinal Cord Injury
Intervention: Device: The VSail-Access simulator
2 Completed Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials
Condition: Respiratory Distress Syndrome, Adult
3 Recruiting Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort
Conditions: Sleep Apnea Hypopnea Syndrome;   COPD;   Emphysema;   Lung Cancer
Intervention: Other: poligraphy
4 Terminated
Has Results
Statins for Acutely Injured Lungs From Sepsis
Conditions: Sepsis;   Acute Lung Injury
Interventions: Drug: Rosuvastatin;   Drug: Placebo
5 Completed Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Intervention: Drug: sirolimus and hydroxychloroquine
6 Recruiting Sleep Apnea in Lung Cancer: A Prospective Study
Conditions: Lung Cancer;   Sleep-Disordered Breathing
Intervention: Other: Sleep testing
7 Recruiting Sustained Aeration of Infant Lungs Trial
Conditions: Preterm Birth;   Extreme Prematurity
Interventions: Procedure: Sustained Inflation;   Procedure: Standard of Care
8 Terminated Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
Condition: Type 2 Diabetes
Interventions: Drug: liraglutide;   Drug: placebo injection
9 Unknown  Safety of Intravenous Thrombolytics in Stroke on Awakening
Condition: Stroke
Intervention: Drug: rt-PA
10 Unknown 
Has Results
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Raltegravir;   Drug: GSK1349572 Placebo;   Drug: Raltegravir Placebo
11 Recruiting Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
Condition: Diabetic Macular Edema
Interventions: Drug: Conbercept;   Other: Sham injection;   Procedure: Laser;   Other: Sham laser
12 Recruiting Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe
Condition: Sea Sickness
Intervention: Other: sea sickness questionnaires
13 Recruiting A Study To Evaluate Ara-C and Idarubicin in Combination With the Selective Inhibitor Of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Relapsed Or Refractory AML
Condition: Acute Myeloid Leukemia (Relapsed/Refractory)
Interventions: Drug: Selinexor;   Drug: Idarubcin;   Drug: Cytarabine
14 Active, not recruiting Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment
Condition: Hepatitis C Virus
Interventions: Drug: Paritaprevir;   Drug: Ritonavir;   Drug: Dasabuvir;   Drug: Ombitasvir;   Drug: Ribavirin
15 Completed Cardiovascular Risk in General Practice in France: Cardiovascular Risk Week
Condition: Healthy
16 Not yet recruiting The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
Condition: Headache
Interventions: Drug: Prochlorperazine;   Drug: Ketamine;   Drug: Diphenhydromine;   Drug: Ondansetron;   Drug: Normal Saline

Indicates status has not been verified in more than two years